CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleMarket cap is $4.72B, above the global median of $1.15B
- Interpretations10 currently firing — 10
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.72BUSDvs all stocks (USD)
Trailing P/E
54.75xvs Diagnostics & Research peers
Revenue (TTM)
541.74MUSDvs all stocks (USD)
Profit Margin
16.25%vs Diagnostics & Research peers
Beta
1.93xvs all stocks
52-Week Change
156.75%vs all stocks
Market Capitalization
4.72BUSDvs all stocks (USD)
Enterprise Value
4.32BUSDvs all stocks (USD)
Trailing P/E
54.75xvs Diagnostics & Research peers
Forward P/E
30.94xvs Diagnostics & Research peers
PEG Ratio
0.1825xvs Diagnostics & Research peers
Price to Sales (TTM)
8.71xvs Diagnostics & Research peers
Price to Book (MRQ)
3.58xvs Diagnostics & Research peers
Enterprise to Revenue
7.97xvs Diagnostics & Research peers
Enterprise to EBITDA
41.44xvs Diagnostics & Research peers
Gross Margin
72.74%vs Diagnostics & Research peers
Profit Margin
16.25%vs Diagnostics & Research peers
Operating Margin
16.28%vs Diagnostics & Research peers
Return on Assets (TTM)
3.76%vs Diagnostics & Research peers
Return on Equity (TTM)
6.93%vs Diagnostics & Research peers
Revenue (TTM)
541.74MUSDvs all stocks (USD)
Revenue per Share (TTM)
6.86USDUpdated Jul 19, 2026Quarterly Revenue Growth
21.50%vs Diagnostics & Research peers
Gross Profit (TTM)
394.97MUSDvs all stocks (USD)
EBITDA (TTM)
138.95MUSDvs all stocks (USD)
Net Income (TTM)
88.01MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
307.40%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
166.16MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
104.51MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Diagnostics & Research peers
Revenue
517.14MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
154.61MUSDFY2025 · Dec 31, 2025Gross Profit
362.53MUSDFY2025 · Dec 31, 2025Operating Income
78.28MUSDvs all stocks (USD)
Pre-tax Income
68.20MUSDFY2025 · Dec 31, 2025Income Tax Expense
1.85MUSDFY2025 · Dec 31, 2025Net Income
66.35MUSDFY2025 · Dec 31, 2025EBIT
68.20MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
112.86MUSDFY2025 · Dec 31, 2025Research & Development
70.81MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
210.95MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
12.72MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
1.00KUSDFY2025 · Dec 31, 2025EPS (Basic)
0.8400USDFY2025 · Dec 31, 2025EPS (Diluted)
0.8200USDFY2025 · Dec 31, 2025Basic Shares Outstanding
78.58MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
78.58MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
66.35MUSDFY2025 · Dec 31, 2025Operating Cash Flow
111.92MUSDFY2025 · Dec 31, 2025Free Cash Flow
102.24MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
364.23MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
66.35MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
21.41MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-581.00KUSDFY2025 · Dec 31, 2025Stock-based Compensation
43.60MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-12.30MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-708.00KUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-1.04MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-4.82MUSDFY2025 · Dec 31, 2025Capital Expenditures
-9.68MUSDFY2025 · Dec 31, 2025Net Acquisitions
-2.85MUSDFY2025 · Dec 31, 2025Purchase of Investments
-150.00MUSDFY2025 · Dec 31, 2025Sale of Investments
153.31MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-9.21MUSDFY2025 · Dec 31, 2025Other Financing Charges
-18.30MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-18.30MUSDFY2025 · Dec 31, 2025Shares Outstanding
79.79MSharesUpdated Jul 19, 2026Float Shares
79.28MSharesUpdated Jul 19, 2026Shares Short
6.72MSharesUpdated Jul 19, 2026Short Ratio
4.34daysvs all stocks
Short % of Shares Outstanding
9.96%vs all stocks
% Held by Insiders
0.54%vs all stocks
% Held by Institutions
112.56%vs all stocks
Total Cash (MRQ)
439.06MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
5.50USDUpdated Jul 19, 2026Total Debt (MRQ)
39.33MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0293xvs Diagnostics & Research peers
Current Ratio (MRQ)
9.30xvs Diagnostics & Research peers
Book Value per Share (MRQ)
16.50USDUpdated Jul 19, 2026Total Assets
1.41BUSDvs all stocks (USD)
Total Current Assets
488.38MUSDFY2025 · Dec 31, 2025Total Liabilities
96.44MUSDFY2025 · Dec 31, 2025Total Non-current Assets
917.64MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
36.51MUSDFY2025 · Dec 31, 2025Total Current Liabilities
59.94MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
362.58MUSDFY2025 · Dec 31, 2025Other Short-term Investments
50.31MUSDFY2025 · Dec 31, 2025Accounts Receivable
44.66MUSDFY2025 · Dec 31, 2025Inventory
20.55MUSDFY2025 · Dec 31, 2025Accounts Payable
4.59MUSDFY2025 · Dec 31, 2025Short-term Debt
4.05MUSDFY2025 · Dec 31, 2025Deferred Revenue
1.16MUSDFY2025 · Dec 31, 2025Other Current Liabilities
1.33MUSDFY2025 · Dec 31, 2025Long-term Debt
35.60MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
257.00KUSDFY2025 · Dec 31, 2025Common Stock (Book)
79.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-377.63MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
1.31BUSDvs all stocks (USD)
52-Week Low
22.92USDUpdated Jul 19, 202652-Week High
60.91USDUpdated Jul 19, 202652-Week Change
156.75%vs all stocks
Beta
1.93xvs all stocks
50-Day MA
50.08USDUpdated Jul 19, 2026200-Day MA
40.84USDUpdated Jul 19, 2026Avg 10-Day Volume
1.05MSharesUpdated Jul 19, 2026Avg 30-Day Volume
1.35MSharesUpdated Jul 19, 2026Diluted EPS (TTM)
1.08USDUpdated Jul 19, 2026Other Income / Expense
-22.80MUSDFY2025 · Dec 31, 202510 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Diagnostic
Goodwill-Heavy Equity
Equity looks heavy for the industry, but much of it is goodwill from past acquisitions.
Reads
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Diagnostic
High OCF-to-NI With Multi-Year Gross-Profit Growth and Elevated-Margin-With-Deceleration
Cash covers reported profit and gross profit is up, with margins high and growth slowing.
Reads
Cash-Backed Growth Configuration
Revenue has grown steadily, and the cash arriving matches reported profit.
Reads
Cash Backing With OCF Coverage And Cash Near Total Debt
Cash on hand covers most or all of its total debt, and cash flow matches reported earnings.
Reads
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
Three Turnover Ratios Elevated
Collects fast, clears inventory fast, and pays suppliers fast too.
Reads
Where is this company structurally exposed?
SBC-to-Net-Income Elevated, SBC-to-Revenue Elevated, And Diluted Share Count Growing (6Y CAGR)
Pay in shares is large next to its revenue and its profit, and the share count keeps rising.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Market cap is $4.72B, above the global median of $1.15BNotable
Market cap (USD): 4,718,139,217Global Median: 1,146,734,693.424
Revenue is $541.74M, above the global median of $520.53MNotable
Revenue (USD): 541,742,976Global Median: 520,528,949.311
Levered free cash flow is $104.51M, above the global median of $16.24MNotable
Levered free cash flow (USD): 104,506,000Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Guangdong Kingshine Electronic Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
CSW Industrials Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Estun Automation Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Soitec SA
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Iray Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRule
Eeverdisplay Optronics (Shanghai) Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Far Eastern New Century Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Rigetti Computing Inc
Tier 1ProductionThroughput-Bound ConversionInterfaceSenseMaking
Trex Company, Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Western Superconducting Technologies Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Agnico Eagle Mines Limited
6 interpretationsCash-Backed Growth ConfigurationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesCash-Flow Ratios ElevatedOperating Income Growing With Multi-Year Revenue GrowthHigh OCF-to-NI With Multi-Year Gross-Profit Growth and Elevated-Margin-With-DecelerationCash Backing With OCF Coverage And Cash Near Total Debt
Kanzhun Ltd.
6 interpretationsCash-Backed Growth ConfigurationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesCash-Flow Ratios ElevatedOperating Income Growing With Multi-Year Revenue GrowthHigh OCF-to-NI With Multi-Year Gross-Profit Growth and Elevated-Margin-With-DecelerationCash Backing With OCF Coverage And Cash Near Total Debt
Medpace Holdings Inc.
6 interpretationsCash-Backed Growth ConfigurationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesCash-Flow Ratios ElevatedOperating Income Growing With Multi-Year Revenue GrowthHigh OCF-to-NI With Multi-Year Gross-Profit Growth and Elevated-Margin-With-DecelerationCash Backing With OCF Coverage And Cash Near Total Debt